Pulmonary diseases that cause abnormal lung parenchymal density: is this a problem in lung cancer screening?
Open Access
- 22 September 2022
- journal article
- letter
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (4) , e20220002
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screeningInsights into Imaging, 2021
- Screening for Lung Cancer: Incidental Pulmonary Parenchymal FindingsAmerican Journal of Roentgenology, 2018
- The influence of inspiratory effort and emphysema on pulmonary nodule volumetry reproducibilityClinical Radiology, 2017
- Use of Volumetry for Lung Nodule Management: Theory and PracticeRadiology, 2017
- Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017Radiology, 2017
- CorrectionThorax, 2015
- British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICEThorax, 2015
- Quantitative Computed Tomography in Chronic Obstructive Pulmonary DiseaseJournal of Thoracic Imaging, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011